glycosaminoglycan isolated from the urine of a patient with the hunter syndrome was composed of heparan sulfate ( 59.9 % ) , dermatan sulfate ( 30.6 % ) and chondroitin sulfate ( 9.5 % ) , and was heterogeneous in molecular weight ( 1,500-10,000 ) and in sulfate content ( 0.35-2.05 moles/mole of hexosamine ) .
C0017973
glycosaminoglycan
C0019143
heparan sulfate